Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Medical Information & Treatment Guide
Hidradenitis suppurativa (ICD-10: L73.2) is a chronic, inflammatory skin condition characterized by painful nodules, abscesses, and scarring, primarily affecting areas where skin rubs together.
Prevalence
1.0%
Common Drug Classes
Clinical information guide
Hidradenitis suppurativa (HS), sometimes referred to as acne inversa, is a chronic, non-contagious inflammatory skin disease. It is characterized by recurrent, painful nodules (lumps), abscesses (pus-filled pockets), and the formation of sinus tracts (tunnels under the skin) that eventually lead to significant scarring. Unlike common acne, HS occurs deep within the skin around hair follicles in areas containing apocrine sweat glands, such as the armpits, groin, buttocks, and under the breasts.
The pathophysiology of HS involves the occlusion (blockage) of the hair follicle. This blockage leads to a buildup of keratin and bacteria, causing the follicle to rupture internally. This rupture triggers a massive inflammatory response from the immune system, resulting in the characteristic painful swelling and eventual tissue destruction. It is not caused by poor hygiene, and it cannot be transmitted from person to person.
Epidemiological data suggests that HS is more common than previously thought, though it remains frequently misdiagnosed. According to research published in the Journal of the American Academy of Dermatology (JAAD, 2023), the estimated prevalence in the United States is approximately 0.1% to 1% of the population. However, some global studies suggest rates as high as 4% in specific demographics.
Data from the National Institutes of Health (NIH, 2024) indicates that the condition disproportionately affects women—who are three times more likely to develop HS than men—and typically emerges after puberty, most commonly in the second or third decade of life. There is also a higher incidence reported among Black and biracial individuals, which researchers believe may be linked to both genetic factors and socioeconomic disparities in healthcare access.
Clinical severity is most commonly classified using the Hurley Staging System, which helps healthcare providers determine the appropriate level of intervention:
HS has one of the highest impacts on quality of life among dermatological conditions. The chronic pain, malodorous discharge from draining wounds, and restricted mobility due to scarring can lead to significant psychological distress. Patients often report social isolation, depression, and anxiety. Furthermore, the condition can interfere with professional life; a 2022 study in British Journal of Dermatology found that patients with Hurley Stage III HS have significantly higher rates of work absenteeism and disability compared to the general population.
Detailed information about Hidradenitis Suppurativa
The earliest indicators of hidradenitis suppurativa (HS) are often subtle and can be mistaken for common skin issues like ingrown hairs or boils. Patients may first notice a persistent, itchy, or slightly painful bump in an area where skin rubs together. These early lesions may disappear and reappear in the same location over several weeks or months, which is a hallmark sign that the condition is more than a simple infection.
As the condition progresses, the symptoms become more distinct and severe:
Answers based on medical literature
Currently, there is no known permanent cure for hidradenitis suppurativa, as it is a chronic inflammatory condition. However, the disease is highly manageable with modern medical interventions, including biologics and surgical procedures. Many patients are able to achieve long-term remission where they experience few to no active flares. The goal of treatment is to control inflammation, prevent new lesions, and manage existing scars. Early diagnosis is the most critical factor in achieving a positive long-term outcome.
No, hidradenitis suppurativa is absolutely not caused by poor hygiene or a lack of cleanliness. It is an inflammatory condition that begins deep within the hair follicle, far below the surface of the skin where washing occurs. Using harsh soaps or excessive scrubbing can actually irritate the skin and potentially worsen a flare-up. Education is vital to remove the stigma associated with the condition, as it is an immune-mediated disease rather than an infection. Understanding this helps patients focus on appropriate medical treatments rather than ineffective over-the-counter cleansers.
This page is for informational purposes only and does not replace medical advice. For treatment of Hidradenitis Suppurativa, consult with a qualified healthcare professional.
In some cases, HS may present with systemic symptoms during a severe flare-up, including low-grade fever, malaise (general feeling of being unwell), and joint pain. Some patients also experience "secondary infection" symptoms if the open tracts become colonized by aggressive bacteria, though the primary disease itself is inflammatory rather than infectious.
In Stage I, symptoms are limited to occasional lumps. In Stage II, the symptoms become more persistent with visible scarring and the first appearance of tunnels. By Stage III, the affected area may be entirely covered in interconnected lumps and scars, with constant drainage and significant physical discomfort.
> Important: While HS is a chronic condition, certain symptoms require immediate medical evaluation to prevent sepsis or severe tissue damage. Seek emergency care if you experience:
> - High fever (over 103°F) and chills associated with a skin flare.
> - Rapidly spreading redness, warmth, or red streaks emanating from a nodule (signs of cellulitis).
> - Severe, unbearable pain that prevents movement.
> - Confusion or extreme lethargy accompanying a skin infection.
In women, symptoms often fluctuate with the menstrual cycle, suggesting a hormonal component; flares are common just before menstruation. In men, HS is more likely to manifest on the back of the neck, ears, and in the perianal region. While rare in children, pediatric HS tends to be associated with underlying endocrine (hormonal) abnormalities.
The exact cause of hidradenitis suppurativa remains a subject of intense clinical research. The current scientific consensus, as detailed in Nature Reviews Disease Primers (2021), suggests that HS is an immune-mediated inflammatory disorder. It begins with follicular hyperkeratosis, a process where the hair follicle becomes clogged with keratin (a skin protein). This leads to the dilation and eventual rupture of the follicle, spilling its contents into the surrounding dermis (deep skin layer). The immune system perceives this as a foreign threat, launching a massive inflammatory response involving cytokines like TNF-alpha and Interleukin-17.
According to the Journal of Investigative Dermatology (2022), individuals who smoke and have a high BMI are at the highest risk for severe disease progression. Furthermore, those with a history of severe acne or pilonidal cysts have a higher statistical likelihood of developing HS. Black women in the U.S. have the highest reported incidence rates, potentially due to a combination of genetic predisposition and environmental stressors.
While the underlying genetic predisposition cannot be changed, the severity and frequency of flares can often be reduced through early intervention. The American Academy of Dermatology (AAD) recommends weight management and smoking cessation as the primary evidence-based strategies for preventing the progression from Hurley Stage I to more severe stages. There is currently no screening test for HS; diagnosis relies on clinical awareness.
The diagnosis of hidradenitis suppurativa is primarily clinical, meaning it is based on the patient's history and the physical appearance of the skin. There is no single blood test or imaging study that can definitively confirm HS. On average, patients experience a delay of 7 to 10 years from their first symptom to a formal diagnosis, often because the condition is mistaken for simple boils or staph infections.
A healthcare provider will examine the affected areas, looking for the "triple threat" of HS diagnosis: typical lesions (nodules, abscesses, or blackheads), typical locations (axilla, groin, inframammary folds), and recurrence (lesions that return at least twice in six months).
While not used to diagnose HS itself, certain tests help rule out other conditions or assess severity:
Clinicians use the Dessau Criteria for diagnosis, which requires:
Conditions that mimic HS include:
The primary goals of treating hidradenitis suppurativa (HS) are to reduce the frequency and severity of flares, alleviate pain, heal existing lesions, and prevent the progression of scarring and sinus tract formation. Successful management often requires a multidisciplinary approach involving dermatologists, surgeons, and primary care providers.
According to the North American Clinical Management Guidelines for Hidradenitis Suppurativa (2019, updated 2023), first-line treatment for mild cases typically involves topical therapies and lifestyle modifications. For more moderate cases, oral therapies are introduced early to prevent permanent tissue damage.
If first-line treatments are insufficient, healthcare providers may consider immunosuppressants or combination antibiotic cocktails. In some cases, zinc supplements are used as an adjunctive anti-inflammatory therapy.
HS is a chronic condition, and treatment is often long-term. Patients on biologics or long-term antibiotics require regular blood work to monitor liver and kidney function.
> Important: Talk to your healthcare provider about which approach is right for you.
Dietary choices can significantly influence HS inflammation. A study in the Journal of Clinical and Aesthetic Dermatology (2022) suggested that a Low Glycemic Index (GI) Diet may reduce flares by lowering insulin levels, which in turn reduces androgen production. Some patients also find relief by eliminating dairy or brewer's yeast, though more large-scale clinical trials are needed to confirm these benefits. Focus on anti-inflammatory foods like leafy greens, berries, and fatty fish (rich in Omega-3s).
Exercise is vital for weight management, which reduces skin-on-skin friction. However, sweat and friction during exercise can trigger flares. To stay active safely:
Chronic pain from HS can disrupt sleep, which in turn increases inflammation. Use specialized pillows to take pressure off affected areas (like the axilla). Maintaining a consistent sleep schedule helps regulate the immune system.
Stress is a well-documented trigger for HS flares. Evidence-based techniques such as Mindfulness-Based Stress Reduction (MBSR), deep breathing exercises, and cognitive-behavioral therapy (CBT) can help patients manage the emotional burden of a chronic skin condition.
Caregivers should focus on providing emotional support and assisting with wound care. Helping the patient maintain a sterile environment for dressing changes and encouraging adherence to treatment plans are critical roles for family members.
The prognosis for HS varies significantly based on how early the condition is diagnosed and managed. While there is currently no permanent cure, many patients achieve long-term remission with a combination of medical and surgical treatments. According to a 2023 report in The Lancet, early intervention significantly reduces the risk of progressing to Hurley Stage III.
If left untreated, HS can lead to:
Management is a lifelong process. Regular follow-ups with a dermatologist (every 3-6 months) are necessary to adjust medications and monitor for complications. Relapse is common if triggers like smoking or high weight are not addressed.
Patients can lead full, active lives by joining support groups (such as Hope for HS) and working closely with a medical team. Using specialized dressings and finding the right combination of therapies can keep symptoms manageable.
Contact your healthcare provider if you notice a new area of involvement, if your current medication causes side effects, or if a previously stable nodule becomes significantly more painful or begins to drain excessively.
Emerging research suggests that dietary changes can play a significant role in managing HS symptoms for some individuals. Specifically, diets that reduce insulin spikes—such as low-glycemic index diets—have shown promise in clinical studies. Some patients also report fewer flares when they eliminate dairy or brewer's yeast, which may trigger specific inflammatory pathways. While diet alone is rarely enough to treat moderate-to-severe HS, it is an excellent adjunctive therapy. You should consult with a healthcare provider or a registered dietitian before making significant restrictive dietary changes.
There is a strong genetic component to hidradenitis suppurativa, with approximately one-third of patients having a first-degree relative with the condition. Research has identified specific gene mutations, particularly in the gamma-secretase complex, that are linked to familial cases of HS. However, having the genetic marker does not guarantee that an individual will develop the disease. Environmental factors, such as smoking and body weight, often interact with genetic predisposition to trigger the onset of symptoms. If you have a family history, being vigilant about early signs can lead to faster diagnosis.
Exercise is highly recommended for HS patients as it helps with weight management and reduces systemic inflammation. However, it is important to modify activities to prevent mechanical friction and excessive sweating in sensitive areas. Opting for loose, breathable fabrics and choosing low-friction exercises like swimming or cycling can help minimize the risk of a flare. It is also essential to wash the affected areas gently and promptly after physical activity. With the right precautions, exercise can be a vital part of a comprehensive HS management plan.
The progression of HS varies between individuals; while it is a progressive disease for some, others may have stable symptoms for decades. Without treatment, the condition often moves from Hurley Stage I (isolated lumps) to Stage III (extensive scarring and tunnels). However, for many women, symptoms may actually improve after menopause, suggesting that hormonal shifts play a role in the disease's activity. Consistent medical management and lifestyle changes are the best ways to prevent the condition from worsening over time. Early intervention is key to stopping the cycle of inflammation and scarring.
HS does not typically affect fertility, but pregnancy can have a variable impact on the condition's symptoms. Some women experience a significant improvement in their skin during pregnancy due to hormonal changes, while others may face increased flares. It is crucial to work closely with both a dermatologist and an obstetrician, as some HS medications (like certain retinoids or antibiotics) are not safe for use during pregnancy. Managing pain and preventing infection are the primary goals for pregnant patients with HS. Most women with HS can have healthy pregnancies and deliveries with proper medical coordination.
Common triggers for hidradenitis suppurativa flares include high levels of stress, hormonal fluctuations (such as the menstrual cycle), and excessive heat or humidity. Smoking is perhaps the most significant external trigger, as nicotine is known to promote follicular blockage and inflammation. Mechanical friction from tight clothing or repetitive movements can also irritate the skin and initiate a new nodule. Some patients also identify specific foods, like high-sugar items or dairy, as personal triggers. Identifying and avoiding these triggers is a cornerstone of successful long-term management.
No, hidradenitis suppurativa is not a form of skin cancer; it is a chronic inflammatory disorder. However, in very rare cases of long-standing, severe HS with extensive scarring, a type of skin cancer called squamous cell carcinoma can develop within the affected tissue. This usually occurs after decades of active disease and is most commonly seen in the perianal area. Regular skin checks by a dermatologist are important to monitor for any unusual changes in chronic scars. Early treatment of HS reduces the risk of these rare but serious complications.
While hidradenitis suppurativa most commonly begins in young adulthood, it can occasionally occur in children, particularly as they approach puberty. Pediatric HS is often associated with early-onset puberty or other underlying hormonal imbalances. When it occurs in younger children, doctors may investigate for metabolic or endocrine issues. Treatment for children is similar to adults but requires careful selection of medications to ensure they do not interfere with growth and development. Early diagnosis in children is vital to prevent the physical and psychological scarring that can occur during formative years.
Clindamycin Phosphate And Tretinoin Gel 1.2%/0.025%
Clindamycin
Cleocin Hydrochloride
Clindamycin
Clindamycin Hydrochloride
Clindamycin
Clindamycin Phosphate
Clindamycin
Cleocin
Clindamycin
Acnil
Clindamycin
Cleocin Phosphate
Clindamycin
Cleocin T
Clindamycin
Clindamycin
Clindamycin
Clindamycin Phoaphate Topical Solution Usp, 1%
Clindamycin
Clindacin
Clindamycin
Clindamycin Phosphate And Tretinoin
Clindamycin
Clindamycin Hcl
Clindamycin
Clindamycin In 5 Percent Dextrose
Clindamycin
Clindesse
Clindamycin
+ 106 more drugs